Olema Oncology to Present at Oppenheimer 33rd Annual
SAN FRANCISCO, March 02, 2023 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq:
Globe Newswire3-03-2023, 04:07
Ingredion Incorporated Reports Strong 2024 Fourth Quarter and Full-Year Results 4-02-2025, 18:05